EPISODE · Apr 20, 2026 · 57 MIN
Ep 68 The Liquid Marijuana: From Reefer Madness to Medical Marijuana: Cannabis in Film, Research & Global Polic
from Medical Media Mixer: The Perfect Cocktail · host medicalmediamixer
Cannabis has gone from 1930s propaganda hysteria to modern-day legalization — but what does the science actually say? In this special 4/20 episode, we break down how marijuana has been portrayed in film — from Reefer Madness (1936) to Pineapple Express (2008) — and how those cultural shifts shaped public perception. Then we dive into the medical reality: FDA-approved cannabinoid medications, off-label uses, safety concerns, and what the evidence really shows for anxiety, depression, PTSD, insomnia, pain, and more. We also explore the legal gray zone in the United States, how Schedule I status limits research, and how countries like Canada, Israel, Germany, and the UK approach medical cannabis. Between fear-based propaganda and “it cures everything” claims, the truth is far more nuanced. Primary JAMA Review (Core Episode Source) Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic Use of Cannabis and Cannabinoids. JAMA. 2025. doi:10.1001/jama.2025.19433 https://doi.org/10.1001/jama.2025.19433 Epilepsy & Epidiolex Cross JH, Cock H. A Perspective on Cannabinoids for Treating Epilepsy: Do They Really Change the Landscape? Neuropharmacology. 2020;170:107861. https://doi.org/10.1016/j.neuropharm.2019.107861 Neuropathic Pain Inglet S, Winter B, Yost SE, et al. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature. Annals of Pharmacotherapy. 2020;54(11):1109–1143. https://doi.org/10.1177/1060028020930189 MS Spasticity / Nabiximols Hill KP. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA. 2015;313(24):2474–83. https://doi.org/10.1001/jama.2015.6199 Jazz Pharmaceuticals — RELEASE MSS1 Phase 3 Trial Results (Nabiximols) https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-announces-top-line-results-phase-3-trial PTSD Rodas JD, George TP, Hassan AN. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters. J Clin Psychiatry. 2024;85(1):23r14862. https://doi.org/10.4088/JCP.23r14862 VA/DoD Clinical Practice Guideline for PTSD (2023) — Cannabis recommendation https://www.ptsd.va.gov/professional/treat/cooccurring/marijuana_ptsd_vets.asp Depression & Mood Disorders Black N, Stockings E, Campbell G, et al. Cannabinoids for the Treatment of Mental Disorders and Symptoms of Mental Disorders: A Systematic Review and Meta-Analysis. Lancet Psychiatry. 2019;6(12):995–1010. https://doi.org/10.1016/S2215-0366(19)30401-8 Tourjman SV, Buck G, Jutras-Aswad D, et al. CANMAT Task Force Report: Cannabis Use in Bipolar Disorder and Major Depressive Disorder. Can J Psychiatry. 2023;68(5):299–311. https://doi.org/10.1177/07067437221099769 de Bode N, Kroon E, Sznitman SR, Cousijn J. The Differential Effects of Medicinal Cannabis on Mental Health: A Systematic Review. Clin Psychol Rev. 2025;118:102581. https://doi.org/10.1016/j.cpr.2025.102581 Wolinsky D, et al. Acute and Chronic Effects of Medicinal Cannabis Use on Anxiety and Depression in a Prospective Cohort. J Affect Disord. 2025;390:119829. https://doi.org/10.1016/j.jad.2025.119829 Anxiety Roberts L, Sorial E, Budgeon CA, et al. Medicinal Cannabis in the Management of Anxiety Disorders: A Systematic Review. Psychiatry Research. 2025;350:116552. https://doi.org/10.1016/j.psychres.2025.116552 Stanciu CN, Brunette MF, Teja N, Budney AJ. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review. Psychiatr Serv. 2021;72(4):429–436. https://doi.org/10.1176/appi.ps.202000189 Insomnia da Silva GHS, Barbosa EC, de Lima FR, et al. Effectiveness of Cannabinoids on Subjective Sleep Quality: A Systematic Review and Meta-Analysis. Sleep Medicine Reviews. 2025;84:102156. https://doi.org/10.1016/j.smrv.2025.102156 Alzheimer's Disease Bosnjak Kuharic D, Markovic D, Brkovic T, et al. Cannabinoids for the Treatment of Dementia. Cochrane Database Syst Rev. 2021;9:CD012820. https://doi.org/10.1002/14651858.CD012820.pub2 Tyrakis P, Agridi C, Kourti M. A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease Across a Decade of Research. Int J Mol Sci. 2024;25(16):8630. https://doi.org/10.3390/ijms25168630 Cardiovascular Risk Page RL, Allen LA, Kloner RA, et al. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2020;142(10):e131–e152. https://doi.org/10.1161/CIR.0000000000000883 Overall Risk-Benefit / Umbrella Review Solmi M, De Toffol M, Kim JY, et al. Balancing Risks and Benefits of Cannabis Use: Umbrella Review of Meta-Analyses of RCTs and Observational Studies. BMJ. 2023;382:e072348. https://doi.org/10.1136/bmj-2022-072348 Cannabinoid Hyperemesis Syndrome (CHS) StatPearls — Cannabinoid Hyperemesis Syndrome (NCBI Bookshelf) https://www.ncbi.nlm.nih.gov/books/NBK549915/ Cedars-Sinai — Cannabinoid Hyperemesis Syndrome https://www.cedars-sinai.org/health-library/diseases-and-conditions/c/cannabinoid-hyperemesis-syndrome.html Cleveland Clinic — Cannabis Hyperemesis Syndrome https://my.clevelandclinic.org/health/diseases/21665-cannabis-hyperemesis-syndrome UCHealth — What is CHS? Leading Cause of Marijuana-Related ER Visits https://www.uchealth.org/today/what-is-chs-cannabinoid-hyperemesis-syndrome-leading-cause-of-marijuana-related-er-visits/ Clinical Practice Guidelines & Institutional Positions American Psychiatric Association — Resource Document on Cannabidiols (2023) https://www.psychiatry.org/File%20Library/Psychiatrists/Directories/Library-and-Archive/resource_documents/2023-resource-document-cannabidiol.pdf Sazegar P. Cannabis Essentials: Tools for Clinical Practice. Am Fam Physician. 2021;104(6):598–608. https://www.aafp.org/pubs/afp/issues/2021/1200/p598.html FILM REFERENCES Reefer Madness (1936) — Wikipedia https://en.wikipedia.org/wiki/Reefer_Madness Up in Smoke (1978) — Wikipedia https://en.wikipedia.org/wiki/Up_in_Smoke Harold & Kumar Go to White Castle (2004) — Wikipedia https://en.wikipedia.org/wiki/Harold_%26_Kumar_Go_to_White_Castle Pineapple Express (2008) — Wikipedia https://en.wikipedia.org/wiki/Pineapple_Express_(film) Episode Video Reference (YouTube) https://youtu.be/y4xyVl8ZaRU?si=JKWP0nkcP9ZxUFUe Cocktail https://youtu.be/y4xyVl8ZaRU?si=JKWP0nkcP9ZxUFUe Episodes every Monday ⭐️ Subscribe, Rate and Review! 🍸 Recipes drop on socials Discounts: 15% off Comfrt apparel Purple Carrot: 40% off your first box ClassPass: 2 weeks free 15% off non-alcoholic spirits at The Zero Proof 💳 Support us on Patreon | ☕️ Buy Me a Coffee Contains affiliate links. We may earn a commission at no additional cost to you.
Embed this episode
What this episode covers
Cannabis has gone from 1930s propaganda hysteria to modern-day legalization — but what does the science actually say? In this special 4/20 episode, we break down how marijuana has been portrayed in film — from Reefer Madness (1936) to Pineapple Express (2008) — and how those cultural shifts shaped public perception. Then we dive into the medical reality: FDA-approved cannabinoid medications, off-label uses, safety concerns, and what the evidence really shows for anxiety, depression, PTSD, insomnia, pain, and more. We also explore the legal gray zone in the United States, how Schedule I status limits research, and how countries like Canada, Israel, Germany, and the UK approach medical cannabis. Between fear-based propaganda and “it cures everything” claims, the truth is far more nuanced. Primary JAMA Review (Core Episode Source) Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic Use of Cannabis and Cannabinoids. JAMA. 2025. doi:10.1001/jama.2025.19433 https://doi.org/10.1001/jama.2025.19433 Epilepsy & Epidiolex Cross JH, Cock H. A Perspective on Cannabinoids for Treating Epilepsy: Do They Really Change the Landscape? Neuropharmacology. 2020;170:107861. https://doi.org/10.1016/j.neuropharm.2019.107861 Neuropathic Pain Inglet S, Winter B, Yost SE, et al. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature. Annals of Pharmacotherapy. 2020;54(11):1109–1143. https://doi.org/10.1177/1060028020930189 MS Spasticity / Nabiximols Hill KP. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA. 2015;313(24):2474–83. https://doi.org/10.1001/jama.2015.6199 Jazz Pharmaceuticals — RELEASE MSS1 Phase 3 Trial Results (Nabiximols) https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-announces-top-line-results-phase-3-trial PTSD Rodas JD, George TP, Hassan AN. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters. J Clin Psychiatry. 2024;85(1):23r14862. https://doi.org/10.4088/JCP.23r14862 VA/DoD Clinical Practice Guideline for PTSD (2023) — Cannabis recommendation https://www.ptsd.va.gov/professional/treat/cooccurring/marijuana_ptsd_vets.asp Depression & Mood Disorders Black N, Stockings E, Campbell G, et al. Cannabinoids for the Treatment of Mental Disorders and Symptoms of Mental Disorders: A Systematic Review and Meta-Analysis. Lancet Psychiatry. 2019;6(12):995–1010. https://doi.org/10.1016/S2215-0366(19)30401-8 Tourjman SV, Buck G, Jutras-Aswad D, et al. CANMAT Task Force Report: Cannabis Use in Bipolar Disorder and Major Depressive Disorder. Can J Psychiatry. 2023;68(5):299–311. https://doi.org/10.1177/07067437221099769 de Bode N, Kroon E, Sznitman SR, Cousijn J. The Differential Effects of Medicinal Cannabis on Mental Health: A Systematic Review. Clin Psychol Rev. 2025;118:102581. https://doi.org/10.1016/j.cpr.2025.102581 Wolinsky D, et al. Acute and Chronic Effects of Medicinal Cannabis Use on Anxiety and Depression in a Prospective Cohort. J Affect Disord. 2025;390:119829. https://doi.org/10.1016/j.jad.2025.119829 Anxiety Roberts L, Sorial E, Budgeon CA, et al. Medicinal Cannabis in the Management of Anxiety Disorders: A Systematic Review. Psychiatry Research. 2025;350:116552. https://doi.org/10.1016/j.psychres.2025.116552 Stanciu CN, Brunette MF, Teja N, Budney AJ. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review. Psychiatr Serv. 2021;72(4):429–436. https://doi.org/10.1176/appi.ps.202000189 Insomnia da Silva GHS, Barbosa EC, de Lima FR, et al. Effectiveness of Cannabinoids on Subjective Sleep Quality: A Systematic Review and Meta-Analysis. Sleep Medicine Reviews. 2025;84:102156. https://doi.org/10.1016/j.smrv.2025.102156 Alzheimer's Disease Bosnjak Kuharic D, Markovic D, Brkovic T, et al. Canna
Ready to play
Ep 68 The Liquid Marijuana: From Reefer Madness to Medical Marijuana: Cannabis in Film, Research & Global Polic
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.